Cargando…

Transcriptional response to hepatitis C virus infection and interferon‐alpha treatment in the human liver

Hepatitis C virus (HCV) is widely used to investigate host–virus interactions. Cellular responses to HCV infection have been extensively studied in vitro. However, in human liver, interferon (IFN)‐stimulated gene expression can mask direct transcriptional responses to infection. To better characteri...

Descripción completa

Detalles Bibliográficos
Autores principales: Boldanova, Tujana, Suslov, Aleksei, Heim, Markus H, Necsulea, Anamaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452008/
https://www.ncbi.nlm.nih.gov/pubmed/28360091
http://dx.doi.org/10.15252/emmm.201607006
_version_ 1783240303362179072
author Boldanova, Tujana
Suslov, Aleksei
Heim, Markus H
Necsulea, Anamaria
author_facet Boldanova, Tujana
Suslov, Aleksei
Heim, Markus H
Necsulea, Anamaria
author_sort Boldanova, Tujana
collection PubMed
description Hepatitis C virus (HCV) is widely used to investigate host–virus interactions. Cellular responses to HCV infection have been extensively studied in vitro. However, in human liver, interferon (IFN)‐stimulated gene expression can mask direct transcriptional responses to infection. To better characterize the direct effects of HCV infection in vivo, we analyze the transcriptomes of HCV‐infected patients lacking an activated endogenous IFN system. We show that expression changes observed in these patients predominantly reflect immune cell infiltrates rather than cell‐intrinsic pathways. We also investigate the transcriptomes of patients with endogenous IFN activation, which paradoxically cannot eradicate viral infection. We find that most IFN‐stimulated genes are induced by both recombinant IFN therapy and the endogenous IFN system, but with lower induction levels in the latter, indicating that the innate immune response in chronic hepatitis C is too weak to clear the virus. We show that coding and non‐coding transcripts have different expression dynamics following IFN treatment. Several microRNA primary transcripts, including that of miR‐122, are significantly down‐regulated in response to IFN treatment, suggesting a new mechanism for IFN‐induced expression fine‐tuning.
format Online
Article
Text
id pubmed-5452008
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-54520082017-06-02 Transcriptional response to hepatitis C virus infection and interferon‐alpha treatment in the human liver Boldanova, Tujana Suslov, Aleksei Heim, Markus H Necsulea, Anamaria EMBO Mol Med Research Articles Hepatitis C virus (HCV) is widely used to investigate host–virus interactions. Cellular responses to HCV infection have been extensively studied in vitro. However, in human liver, interferon (IFN)‐stimulated gene expression can mask direct transcriptional responses to infection. To better characterize the direct effects of HCV infection in vivo, we analyze the transcriptomes of HCV‐infected patients lacking an activated endogenous IFN system. We show that expression changes observed in these patients predominantly reflect immune cell infiltrates rather than cell‐intrinsic pathways. We also investigate the transcriptomes of patients with endogenous IFN activation, which paradoxically cannot eradicate viral infection. We find that most IFN‐stimulated genes are induced by both recombinant IFN therapy and the endogenous IFN system, but with lower induction levels in the latter, indicating that the innate immune response in chronic hepatitis C is too weak to clear the virus. We show that coding and non‐coding transcripts have different expression dynamics following IFN treatment. Several microRNA primary transcripts, including that of miR‐122, are significantly down‐regulated in response to IFN treatment, suggesting a new mechanism for IFN‐induced expression fine‐tuning. John Wiley and Sons Inc. 2017-03-30 2017-06 /pmc/articles/PMC5452008/ /pubmed/28360091 http://dx.doi.org/10.15252/emmm.201607006 Text en © 2017 The Authors. Published under the terms of the CC BY 4.0 license This is an open access article under the terms of the Creative Commons Attribution 4.0 (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Boldanova, Tujana
Suslov, Aleksei
Heim, Markus H
Necsulea, Anamaria
Transcriptional response to hepatitis C virus infection and interferon‐alpha treatment in the human liver
title Transcriptional response to hepatitis C virus infection and interferon‐alpha treatment in the human liver
title_full Transcriptional response to hepatitis C virus infection and interferon‐alpha treatment in the human liver
title_fullStr Transcriptional response to hepatitis C virus infection and interferon‐alpha treatment in the human liver
title_full_unstemmed Transcriptional response to hepatitis C virus infection and interferon‐alpha treatment in the human liver
title_short Transcriptional response to hepatitis C virus infection and interferon‐alpha treatment in the human liver
title_sort transcriptional response to hepatitis c virus infection and interferon‐alpha treatment in the human liver
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452008/
https://www.ncbi.nlm.nih.gov/pubmed/28360091
http://dx.doi.org/10.15252/emmm.201607006
work_keys_str_mv AT boldanovatujana transcriptionalresponsetohepatitiscvirusinfectionandinterferonalphatreatmentinthehumanliver
AT suslovaleksei transcriptionalresponsetohepatitiscvirusinfectionandinterferonalphatreatmentinthehumanliver
AT heimmarkush transcriptionalresponsetohepatitiscvirusinfectionandinterferonalphatreatmentinthehumanliver
AT necsuleaanamaria transcriptionalresponsetohepatitiscvirusinfectionandinterferonalphatreatmentinthehumanliver